IRS-2/Akt/GSK-3β/Nrf2 Pathway Contributes to the Protective Effects of Chikusetsu Saponin IVa against Lipotoxicity

Chronic hyperlipidemia leads to pancreatic β-cell apoptosis and dysfunction through inducing oxidative stress. Chikusetsu saponin IVa (CHS) showed antioxidant and antidiabetic properties in our previous studies; however, its protective effects against lipotoxicity-induced β-cell oxidative stress and dysfunction are not clear. This study was designed to investigate the effects of CHS against lipotoxicity-induced β-cell injuries and its possible mechanism involved. High-fat (HF) diet and a low dose of streptozotocin- (STZ-) induced type 2 diabetes mellitus (T2DM) model in vivo and βTC3 cells subjected to 0.5 mM palmitate (PA) to imitate the lipotoxic model in vitro were performed. Pancreatic functions, ROS, and antioxidant protein measurements were performed to evaluate the effects of CHS on cell injuries. Protein expression levels were measured by Western blotting. Furthermore, siRNA-targeted Nrf2, PI3K/Akt inhibitor (LY294002), or GSK-3β inhibitor (LiCl) was used to investigate the crosstalk relationships between proteins. As the results showed, CHS treatment inhibited apoptosis, promoted insulin release, and reduced oxidative stress. CHS treatment significantly increased the expression of Nrf2 in the cytoplasm and nuclear protein. The antioxidative and benefit effects of CHS were inhibited by siNrf2. The phosphorylation of IRS-2, PI3K, Akt, and GSK-3β was markedly increased by CHS which were inhibited by PA. In addition, inhibition of PI3K/Akt or GSK-3β with specific inhibitors dramatically abrogated the protective effects of CHS, revealing that the IRS-2/Akt/GSK-3β signaling axis was involved in the protective effects of CHS. These results demonstrate that CHS protected βTC3 cells against PA-induced oxidative stress and cell dysfunction through Nrf2 by the IRS-2/Akt/GSK-3β-mediated pathway.

[1]  A. Wen,et al.  Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway , 2020, Aging.

[2]  A. Wen,et al.  Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3β/Nrf2 signaling , 2019, Journal of neuroinflammation.

[3]  Guihua Liu,et al.  The PI3K/AKT pathway in obesity and type 2 diabetes , 2018, International journal of biological sciences.

[4]  S. Gersting,et al.  Inborn errors of metabolism and the human interactome: a systems medicine approach , 2018, Journal of Inherited Metabolic Disease.

[5]  D. Tuveson,et al.  Transcriptional Regulation by Nrf2 , 2017, Antioxidants & redox signaling.

[6]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[7]  M. Bugliani,et al.  Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK–NRF2 pathway , 2016, Cell Death and Differentiation.

[8]  F. Giorgino,et al.  Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response. , 2016, Endocrinology.

[9]  A. Wen,et al.  Chikusetsu saponin IVa confers cardioprotection via SIRT1/ERK1/2 and Homer1a pathway , 2015, Scientific Reports.

[10]  Yunchao Su,et al.  The critical role of Akt in cardiovascular function. , 2015, Vascular pharmacology.

[11]  A. Dobrzyń,et al.  Islet β-cell failure in type 2 diabetes--Within the network of toxic lipids. , 2015, Biochemical and biophysical research communications.

[12]  A. Wen,et al.  Insulinotropic effect of Chikusetsu saponin IVa in diabetic rats and pancreatic β-cells. , 2015, Journal of ethnopharmacology.

[13]  A. Wen,et al.  Chikusetsu Saponin IVa Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice via Adiponectin-Mediated AMPK/GSK-3β Pathway In Vivo and In Vitro , 2015, Molecular Neurobiology.

[14]  M. Pal Bhadra,et al.  Garlic Attenuates Cardiac Oxidative Stress via Activation of PI3K/AKT/Nrf2-Keap1 Pathway in Fructose-Fed Diabetic Rat , 2014, PloS one.

[15]  M. Bugliani,et al.  JunB protects β-cells from lipotoxicity via the XBP1–AKT pathway , 2014, Cell Death and Differentiation.

[16]  Haihong Zhou,et al.  Effect of Centella asiatica on Oxidative Stress and Lipid Metabolism in Hyperlipidemic Animal Models , 2014, Oxidative medicine and cellular longevity.

[17]  U. Linnenkamp,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes research and clinical practice.

[18]  J. Chen,et al.  Determination of chikusetsusaponin V and chikusetsusaponin IV in rat plasma by liquid chromatography-mass spectrometry and its application to a preliminary pharmacokinetic study. , 2013, Biomedical chromatography : BMC.

[19]  K. Park,et al.  A Systematic Review of Oxidative Stress and Safety of Antioxidants in Diabetes: Focus on Islets and Their Defense , 2013, Diabetes & metabolism journal.

[20]  P. Sil,et al.  D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. , 2013, Toxicology and applied pharmacology.

[21]  Zhiyong Cheng,et al.  IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. , 2011, The Journal of clinical investigation.

[22]  Weiping Yuan,et al.  Rictor/mTORC2 Is Essential for Maintaining a Balance Between β-Cell Proliferation and Cell Size , 2011, Diabetes.

[23]  Carol Huang,et al.  Participation of Akt, menin, and p21 in pregnancy-induced beta-cell proliferation. , 2011, Endocrinology.

[24]  Jian Li,et al.  NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-Induced Dysfunction and Apoptosis of β-Cells via JNK, p38 MAPK and p53 Pathways , 2010, PloS one.

[25]  Xuefeng Yu,et al.  SREBP‐1c, Pdx‐1, and GLP‐1R involved in palmitate–EPA regulated glucose‐stimulated insulin secretion in INS‐1 cells , 2010, Journal of cellular biochemistry.

[26]  M. Permutt,et al.  Conditional ablation of Gsk-3β in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice , 2010, Diabetologia.

[27]  K. Cusi.  The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes , 2010, Current diabetes reports.

[28]  Nobuo Ochi,et al.  PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells , 2009, Molecular and Cellular Biochemistry.

[29]  R. Mueller,et al.  Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. , 2009, European journal of pharmacology.

[30]  A. I. Rojo,et al.  GSK‐3β down‐regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress , 2008 .

[31]  R. Lupi,et al.  Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences. , 2008, Diabetes & metabolism.

[32]  M. Permutt,et al.  Mice with beta cell overexpression of glycogen synthase kinase-3β have reduced beta cell mass and proliferation , 2008, Diabetologia.

[33]  R. Robertson,et al.  Glucolipotoxicity: fuel excess and beta-cell dysfunction. , 2008, Endocrine reviews.

[34]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[35]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[36]  J. Chan,et al.  Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. , 2006, Free radical biology & medicine.

[37]  P. Ramarao,et al.  Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. , 2005, Pharmacological research.

[38]  Makoto Kobayashi,et al.  Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. , 2005, Antioxidants & redox signaling.

[39]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[40]  Xueying Lin,et al.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. , 2004, The Journal of clinical investigation.

[41]  R. Robertson,et al.  β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .

[42]  N. Morral,et al.  Novel targets and therapeutic strategies for type 2 diabetes , 2003, Trends in Endocrinology & Metabolism.

[43]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[44]  L. Rosenberg,et al.  In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. , 1995, Cell transplantation.

[45]  Yun-ping Zhou,et al.  Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. , 1995, The Journal of clinical endocrinology and metabolism.

[46]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .

[47]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.